Figure 4.

Similar trends in each of the outcomes in the general population with the exception of VTE, raising the possibility that trends observed in the dialysis population were related to secular trends across the entire population rather than changes related to epoetin alfa use are shown. Trends in rates (95% CI) of all-cause death (A), stroke (B), MI (C), the composite endpoint (D), heart failure (E), VTE (F), and transfusion (G) in the non-ESRD Medicare population, 2005–2012. Composite endpoint describes rates of all-cause death, stroke, and MI.